Macquarie lowered the firm’s price target on Cinemark to $21 from $22 and keeps an Outperform rating on the shares. The analyst says U.S. box office sales were $1.09B Q4-to-date through November, flat year-over-year and down 32% versus the same period in 2019. The firm remains comfortable with its Q4 U.S. box office forecast of $2B. Imax and Cinemark remain its top theatre picks.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CNK: